Stockscreener 앱 받기
7.69
1.45%
0.11
시간 외 거래:
7.73
0.04
+0.52%
전일 마감가:
$7.58
열려 있는:
$7.66
하루 거래량:
55,662
Relative Volume:
0.42
시가총액:
$740.65M
수익:
$106.66M
순이익/손실:
$15.16M
주가수익비율:
82.25
EPS:
0.0935
순현금흐름:
$6.37M
1주 성능:
-0.65%
1개월 성능:
+11.13%
6개월 성능:
-30.85%
1년 성능:
-34.94%
1일 변동 폭
$7.6591
$7.91
1주일 범위
$7.02
$8.12
52주 변동 폭
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
명칭
Gyre Therapeutics Inc
전화
(619) 949-3681
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.69 | 688.47M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-26 | 개시 | H.C. Wainwright | Buy |
| 2025-03-11 | 개시 | Noble Capital Markets | Outperform |
| 2021-04-29 | 재개 | Stephens | Overweight |
| 2021-02-10 | 개시 | Piper Sandler | Overweight |
| 2020-05-21 | 개시 | Raymond James | Outperform |
| 2019-01-04 | 개시 | Oppenheimer | Outperform |
| 2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 개시 | Chardan Capital Markets | Buy |
| 2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
| 2016-06-30 | 개시 | Rodman & Renshaw | Buy |
모두보기
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
Price action breakdown for Gyre Therapeutics Inc.Options Play & High Accuracy Swing Trade Signals - Newser
Live market analysis of Gyre Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Will Gyre Therapeutics Inc. see short term momentum2025 Market Outlook & Smart Money Movement Tracker - Newser
Will a bounce in Gyre Therapeutics Inc. offer an exit2025 Market Outlook & Proven Capital Preservation Tips - Newser
Full technical analysis of Gyre Therapeutics Inc. stockJuly 2025 Decliners & Expert Verified Stock Movement Alerts - Newser
Published on: 2025-09-06 21:07:55 - Newser
Gyre Therapeutics Inc.’s volatility index tracking explainedDividend Hike & Expert Approved Momentum Trade Ideas - Newser
What Fibonacci levels say about Gyre Therapeutics Inc. rebound2025 Sector Review & High Yield Stock Recommendations - Newser
Can a trend reversal in Gyre Therapeutics Inc. lead to recoveryOil Prices & Short-Term High Return Ideas - Newser
MACD Cross Could Confirm Trend in Gyre Therapeutics Inc.Market Risk Analysis & Safe Swing Trade Setups - beatles.ru
Is Gyre Therapeutics Inc. meeting your algorithmic filter criteriaMarket Performance Report & Advanced Technical Signal Analysis - Newser
Is Gyre Therapeutics Inc. benefiting from interest rate changesJuly 2025 Technicals & Free Technical Pattern Based Buy Signals - خودرو بانک
Is Gyre Therapeutics Inc. a potential multi baggerJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - خودرو بانک
Gyre Therapeutics’ Strategic Position in the Fibrosis Therapeutics Market - AInvest
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Published on: 2025-09-05 14:39:34 - Newser
Can Gyre Therapeutics Inc. reach all time highs this year2025 Market WrapUp & Stepwise Trade Execution Plans - خودرو بانک
Gyre Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Weekly Top Gainers Trade List - Newser
How to interpret RSI for Gyre Therapeutics Inc. stockQuarterly Investment Review & Free Reliable Trade Execution Plans - Newser
RSI + MACD Show Convergence for Gyre Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - Newser
News impact scoring models applied to Gyre Therapeutics Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - Newser
What is the next catalyst for Gyre Therapeutics Inc.2025 Dividend Review & Precise Swing Trade Alerts - خودرو بانک
Technical analysis overview for Gyre Therapeutics Inc. stockWeekly Market Summary & Fast Entry and Exit Trade Plans - Newser
Gyre Therapeutics Inc. stock trendline breakdownWeekly Earnings Recap & Safe Entry Point Identification - Newser
What is Gyre Therapeutics Inc. s revenue forecastQuarterly Risk Review & Fast Moving Market Watchlists - خودرو بانک
Published on: 2025-09-03 09:00:46 - Newser
Can Gyre Therapeutics Inc. stock outperform in a bear marketTrade Exit Summary & Growth Oriented Trading Recommendations - خودرو بانک
Gyre Therapeutics Inc. stock momentum explainedQuarterly Profit Review & Community Consensus Trade Signals - Newser
Custom watchlist performance reports with Gyre Therapeutics Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Predicting Gyre Therapeutics Inc. trend using moving averagesTrade Volume Summary & Stock Market Timing Techniques - Newser
Real time scanner hits for Gyre Therapeutics Inc. explained2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Forecasting Gyre Therapeutics Inc. price range with options dataWeekly Investment Report & Verified Stock Trade Ideas - Newser
Will Gyre Therapeutics Inc. benefit from sector rotationJuly 2025 Update & Weekly High Momentum Picks - خودرو بانک
Is Gyre Therapeutics Inc. a defensive stock2025 Dividend Review & AI Based Trade Execution Alerts - خودرو بانک
Published on: 2025-09-02 13:14:36 - Newser
Sell Signal: Can Gyre Therapeutics Inc. reach all time highs this year - خودرو بانک
What is Gyre Therapeutics Inc. s P E ratio telling usWeekly Investment Summary & Long-Term Safe Investment Ideas - خودرو بانک
Can Gyre Therapeutics Inc. recover in the next quarterWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN
Gyre Therapeutics Inc (GYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):